We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-13.05%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$287B
AUM Growth
-$45.4B
Cap. Flow
+$4.91B
Cap. Flow %
1.71%
Top 10 Hldgs %
16.91%
Holding
3,742
New
162
Increased
2,018
Reduced
1,243
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 19.98%
2 Healthcare 13.1%
3 Financials 12.8%
4 Consumer Discretionary 9.34%
5 Industrials 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTK icon
3451
Flotek Industries
FTK
$847M
$34K ﹤0.01%
5,581
VANI icon
3452
Vivani Medical
VANI
$112M
$34K ﹤0.01%
+5,513
New +$29.7K
PRTK
3453
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$34K ﹤0.01%
17,405
-112,267
-87% -$245K
TPHS
3454
DELISTED
Trinity Place Holdings Inc.com
TPHS
$33K ﹤0.01%
31,763
BCLI
3455
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$32K ﹤0.01%
752
BOXL icon
3456
Boxlight
BOXL
$1.89M
$32K ﹤0.01%
+33
New +$43.9K
CUE icon
3457
Cue Biopharma
CUE
$128M
$32K ﹤0.01%
422
-2,280
-84% -$267K
TLPH icon
3458
Talphera
TLPH
$70.1M
$32K ﹤0.01%
+6,382
New +$29.7K
VNRX icon
3459
VolitionRx Ltd
VNRX
$9.63M
$32K ﹤0.01%
769
NBSE
3460
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$32K ﹤0.01%
+1,486
New +$34.9K
BIOR
3461
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$32K ﹤0.01%
180
ETTX
3462
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$32K ﹤0.01%
+14,236
New +$28.4K
ACIC icon
3463
American Coastal Insurance
ACIC
$515M
$31K ﹤0.01%
19,297
-27,637
-59% -$58.6K
IZEA icon
3464
IZEA Worldwide
IZEA
$59.2M
$31K ﹤0.01%
+8,622
New +$37.1K
LITS
3465
Lite Strategy Inc
LITS
$33.6M
$31K ﹤0.01%
2,526
-34,189
-93% -$372K
VHC icon
3466
VirnetX Holding Corp
VHC
$54.7M
$31K ﹤0.01%
1,305
-7,305
-85% -$203K
WEAV icon
3467
Weave Communications
WEAV
$522M
$31K ﹤0.01%
10,114
QCLS
3468
Q/C Technologies Inc
QCLS
$21.3M
$31K ﹤0.01%
5
PEAR
3469
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$31K ﹤0.01%
19,890
ARDX icon
3470
Ardelyx
ARDX
$1.25B
$30K ﹤0.01%
50,000
-209,422
-81% -$154K
CLSD
3471
DELISTED
Clearside Biomedical
CLSD
$30K ﹤0.01%
1,348
SCTL
3472
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$30K ﹤0.01%
37,047
+8,712
+31% +$9.36K
HALL
3473
DELISTED
Hallmark Financial Services, Inc.
HALL
$30K ﹤0.01%
+1,236
New +$37.4K
TYME
3474
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$30K ﹤0.01%
+106,584
New +$30.7K
ADIL
3475
Adial Pharmaceuticals
ADIL
$7.2M
$29K ﹤0.01%
+34
New +$30.8K

Similar funds

Charles Schwab's Q2 2022 Portfolio in Review

As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
  • Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
  • Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
  • Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
  • Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
  • Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
  • Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.